PUBLICACIÓN

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Agúndez, J.A.G., García-Martín, E., Martínez, C.

2009 Expert Opinion on Drug Metabolism and Toxicology

Medicine (miscellaneous) (Q1), Pharmacology (Q2), Toxicology (Q2)

JCR: 3.076

SJR: 0.951


CITAS

105

DOI

10.1517/17425250902970998

EID

2-s2.0-67649416267

ISSN

1742-5255

BIBTEX

@article{García-Martín2009,title = {Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?},journal = {Expert Opinion on Drug Metabolism and Toxicology},year = {2009},volume = {5},number = {6},pages = {607-620},author = {Ag{\'u}ndez, J.A.G. and Garc{\'i}a-Mart{\'i}n, E. and Mart{\'i}nez, C.}}


AUTORES DE LA UEX